Related Experiment Video
Updated: Jul 18, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
Molecular therapy in the microRNA era
1Molecular Neurogenetics Unit, Massachusetts General Hospital and Harvard Medical School, Boston/Charlestown, MA, USA. twurdinger@partners.org
Abstract:
MicroRNAs (miRNAs) consist of a growing class of non-coding RNAs (ncRNAs) that negatively regulate the expression of genes involved in development, differentiation, proliferation, apoptosis and other important cellular processes. miRNAs are usually 18-25 nt long and are each able to regulate several mRNAs by mechanisms such as incomplete base pairing and Post-Transcriptional Gene Silencing (PTGS). A growing number of reports have shown that aberrant miRNA expression is a common feature of human diseases including cancer, which has sparked interest in targeting these regulators of gene expression as a means of ameliorating these diseases. Here, we review important aspects of miRNA function in normal and pathological states and discuss new modalities of epigenetic intervention strategies that could be used to amend defects in miRNA/mRNA interactions.
Insights
MicroRNAs (miRNAs) are small RNAs regulating gene expression. Aberrant miRNA levels are linked to diseases like cancer, prompting research into epigenetic therapies targeting miRNA defects.
Area of Science:
- Molecular Biology
- Genetics
- Epigenetics
Background:
- MicroRNAs (miRNAs) are non-coding RNAs regulating gene expression.
- They play crucial roles in cellular processes like development and apoptosis.
- Dysregulated miRNA expression is implicated in human diseases, notably cancer.
Purpose of the Study:
- To review the function of miRNAs in normal and pathological conditions.
- To discuss epigenetic intervention strategies for correcting miRNA/mRNA interaction defects.
Main Methods:
- Literature review of miRNA function and disease association.
- Exploration of epigenetic therapeutic approaches.
Main Results:
- miRNAs are key regulators of gene expression through Post-Transcriptional Gene Silencing (PTGS).
- Aberrant miRNA expression is a hallmark of various diseases, including cancer.
- Epigenetic interventions offer potential for therapeutic modulation of miRNA activity.
Conclusions:
- Understanding miRNA roles is vital for disease pathology.
- Targeting miRNA-mediated gene regulation presents a promising therapeutic avenue.
- Epigenetic strategies hold potential for correcting aberrant miRNA/mRNA interactions in disease.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Microorganisms in Medicine and Therapeutics
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi
